Kyverna Therapeutics
KYTX
$15.42
Share price
1.11%
Change (1 day)
N/A
Change (1 year)
Categories
Kyverna Therapeutics (KYTX) - Cash on Hand
Cash on Hand as of December 2023 : $57.54 M
According to Kyverna Therapeutics's latest financial reports the company has $57.54 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Kyverna Therapeutics - Cash on Hand chart (from 2022 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $51.32 M | -32.53% |
| 2021-12-31 | $76.06 M |